カテゴリ： 世界, 医療/バイオ, QYResearch

ピーナッツアレルギー治療薬の世界市場2023年：エピネフリン注射、抗ヒスタミン薬、経口免疫療法、その他

■ 英語タイトル：Global Peanut Allergy Therapeutics Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA6488）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA6488
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：98
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[ピーナッツアレルギー治療薬の世界市場2023年：エピネフリン注射、抗ヒスタミン薬、経口免疫療法、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料はピーナッツアレルギー治療薬のグローバル市場について調査・分析し、世界のピーナッツアレルギー治療薬市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（エピネフリン注射、抗ヒスタミン薬、経口免疫療法、その他）、用途別セグメント分析（病院薬局、小売店薬局、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Mylan、Bayer、UCB Pharma、J & J、Perrigo、GSK、Kaleo、Amneal Pharma、ALK Abello、Aimmune Therapeutics、HUAPONT Pharm、Allergy Therapeutics、ASIT Biotech、Sanofi、DBV Technologies、HAL Allergy、Intrommune Therapeuticsなどが含まれています。ピーナッツアレルギー治療薬のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、ピーナッツアレルギー治療薬市場規模を算出する際に考慮しました。

・ピーナッツアレルギー治療薬市場の概要
- ピーナッツアレルギー治療薬の種類別セグメント
- 世界のピーナッツアレルギー治療薬市場規模：タイプ別分析（エピネフリン注射、抗ヒスタミン薬、経口免疫療法、その他）
- ピーナッツアレルギー治療薬の用途別セグメント
- 世界のピーナッツアレルギー治療薬市場規模：用途別分析（病院薬局、小売店薬局、その他）
- 世界のピーナッツアレルギー治療薬市場規模予測（2018年-2029年）

・ピーナッツアレルギー治療薬市場の成長トレンド
- ピーナッツアレルギー治療薬の地域別市場規模（2018年-2029年）
- ピーナッツアレルギー治療薬市場ダイナミクス
- ピーナッツアレルギー治療薬の業界動向
- ピーナッツアレルギー治療薬市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：エピネフリン注射、抗ヒスタミン薬、経口免疫療法、その他
- 世界のピーナッツアレルギー治療薬のタイプ別市場規模（2018年-2023年）
- 世界のピーナッツアレルギー治療薬のタイプ別市場規模（2024年-2029年）

・用途別セグメント：病院薬局、小売店薬局、その他
- 世界のピーナッツアレルギー治療薬の用途別市場規模（2018年-2023年）
- 世界のピーナッツアレルギー治療薬の用途別市場規模（2024年-2029年）

・ピーナッツアレルギー治療薬の地域別市場規模
- 北米のピーナッツアレルギー治療薬市場規模（2018年-2029年）
- 米国のピーナッツアレルギー治療薬市場規模（2018年-2029年）
- ヨーロッパのピーナッツアレルギー治療薬市場規模（2018年-2029年）
- アジア太平洋のピーナッツアレルギー治療薬市場規模（2018年-2029年）
- 中国のピーナッツアレルギー治療薬市場規模（2018年-2029年）
- 日本のピーナッツアレルギー治療薬市場規模（2018年-2029年）
- 韓国のピーナッツアレルギー治療薬市場規模（2018年-2029年）
- インドのピーナッツアレルギー治療薬市場規模（2018年-2029年）
- オーストラリアのピーナッツアレルギー治療薬市場規模（2018年-2029年）
- 中南米のピーナッツアレルギー治療薬市場規模（2018年-2029年）
- 中東・アフリカのピーナッツアレルギー治療薬市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Mylan、Bayer、UCB Pharma、J & J、Perrigo、GSK、Kaleo、Amneal Pharma、ALK Abello、Aimmune Therapeutics、HUAPONT Pharm、Allergy Therapeutics、ASIT Biotech、Sanofi、DBV Technologies、HAL Allergy、Intrommune Therapeutics

・アナリストの観点/結論

・調査手法と情報源

Peanuts are one of the food allergens most commonly associated with anaphylaxis, a sudden and potentially deadly condition that requires immediate attention and treatment.
Highlights
The global Peanut Allergy Therapeutics market was valued at US$ 953.7 million in 2022 and is anticipated to reach US$ 6416.9 million by 2029, witnessing a CAGR of 37.4% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
United States is the largest consumption place, with a consumption market share nearly 45% in 2019. Following United States, Europe is the second largest consumption place with the consumption market share of 31%.
Market competition is intense. Mylan, Bayer, UCB Pharma, J & J, Perrigo,top 5 players took 52% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Peanut Allergy Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peanut Allergy Therapeutics.
The Peanut Allergy Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Peanut Allergy Therapeutics market comprehensively. Regional market sizes, concerning products by type, by distribution channel, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peanut Allergy Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by distribution channel, and by regions.
By Company
Mylan
Bayer
UCB Pharma
J & J
Perrigo
GSK
Kaleo
Amneal Pharma
ALK Abello
Aimmune Therapeutics
HUAPONT Pharm
Allergy Therapeutics
ASIT Biotech
Sanofi
DBV Technologies
HAL Allergy
Intrommune Therapeutics
Segment by Type
Epinephrine Injection
Antihistamines
Oral Immunotherapy
Other
Segment by Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, distribution channel, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Peanut Allergy Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by distribution channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peanut Allergy Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Epinephrine Injection
1.2.3 Antihistamines
1.2.4 Oral Immunotherapy
1.2.5 Other
1.3 Market by Distribution Channel
1.3.1 Global Peanut Allergy Therapeutics Market Growth by Distribution Channel: 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Peanut Allergy Therapeutics Market Perspective (2018-2029)
2.2 Peanut Allergy Therapeutics Growth Trends by Region
2.2.1 Global Peanut Allergy Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Peanut Allergy Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 Peanut Allergy Therapeutics Forecasted Market Size by Region (2024-2029)
2.3 Peanut Allergy Therapeutics Market Dynamics
2.3.1 Peanut Allergy Therapeutics Industry Trends
2.3.2 Peanut Allergy Therapeutics Market Drivers
2.3.3 Peanut Allergy Therapeutics Market Challenges
2.3.4 Peanut Allergy Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peanut Allergy Therapeutics Players by Revenue
3.1.1 Global Top Peanut Allergy Therapeutics Players by Revenue (2018-2023)
3.1.2 Global Peanut Allergy Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Peanut Allergy Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Peanut Allergy Therapeutics Revenue
3.4 Global Peanut Allergy Therapeutics Market Concentration Ratio
3.4.1 Global Peanut Allergy Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peanut Allergy Therapeutics Revenue in 2022
3.5 Peanut Allergy Therapeutics Key Players Head office and Area Served
3.6 Key Players Peanut Allergy Therapeutics Product Solution and Service
3.7 Date of Enter into Peanut Allergy Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Peanut Allergy Therapeutics Breakdown Data by Type
4.1 Global Peanut Allergy Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global Peanut Allergy Therapeutics Forecasted Market Size by Type (2024-2029)
5 Peanut Allergy Therapeutics Breakdown Data by Distribution Channel
5.1 Global Peanut Allergy Therapeutics Historic Market Size by Distribution Channel (2018-2023)
5.2 Global Peanut Allergy Therapeutics Forecasted Market Size by Distribution Channel (2024-2029)
6 North America
6.1 North America Peanut Allergy Therapeutics Market Size (2018-2029)
6.2 North America Peanut Allergy Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Peanut Allergy Therapeutics Market Size by Country (2018-2023)
6.4 North America Peanut Allergy Therapeutics Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Peanut Allergy Therapeutics Market Size (2018-2029)
7.2 Europe Peanut Allergy Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Peanut Allergy Therapeutics Market Size by Country (2018-2023)
7.4 Europe Peanut Allergy Therapeutics Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Peanut Allergy Therapeutics Market Size (2018-2029)
8.2 Asia-Pacific Peanut Allergy Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Peanut Allergy Therapeutics Market Size by Region (2018-2023)
8.4 Asia-Pacific Peanut Allergy Therapeutics Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Peanut Allergy Therapeutics Market Size (2018-2029)
9.2 Latin America Peanut Allergy Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Peanut Allergy Therapeutics Market Size by Country (2018-2023)
9.4 Latin America Peanut Allergy Therapeutics Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peanut Allergy Therapeutics Market Size (2018-2029)
10.2 Middle East & Africa Peanut Allergy Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Peanut Allergy Therapeutics Market Size by Country (2018-2023)
10.4 Middle East & Africa Peanut Allergy Therapeutics Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Mylan
11.1.1 Mylan Company Detail
11.1.2 Mylan Business Overview
11.1.3 Mylan Peanut Allergy Therapeutics Introduction
11.1.4 Mylan Revenue in Peanut Allergy Therapeutics Business (2018-2023)
11.1.5 Mylan Recent Development
11.2 Bayer
11.2.1 Bayer Company Detail
11.2.2 Bayer Business Overview
11.2.3 Bayer Peanut Allergy Therapeutics Introduction
11.2.4 Bayer Revenue in Peanut Allergy Therapeutics Business (2018-2023)
11.2.5 Bayer Recent Development
11.3 UCB Pharma
11.3.1 UCB Pharma Company Detail
11.3.2 UCB Pharma Business Overview
11.3.3 UCB Pharma Peanut Allergy Therapeutics Introduction
11.3.4 UCB Pharma Revenue in Peanut Allergy Therapeutics Business (2018-2023)
11.3.5 UCB Pharma Recent Development
11.4 J & J
11.4.1 J & J Company Detail
11.4.2 J & J Business Overview
11.4.3 J & J Peanut Allergy Therapeutics Introduction
11.4.4 J & J Revenue in Peanut Allergy Therapeutics Business (2018-2023)
11.4.5 J & J Recent Development
11.5 Perrigo
11.5.1 Perrigo Company Detail
11.5.2 Perrigo Business Overview
11.5.3 Perrigo Peanut Allergy Therapeutics Introduction
11.5.4 Perrigo Revenue in Peanut Allergy Therapeutics Business (2018-2023)
11.5.5 Perrigo Recent Development
11.6 GSK
11.6.1 GSK Company Detail
11.6.2 GSK Business Overview
11.6.3 GSK Peanut Allergy Therapeutics Introduction
11.6.4 GSK Revenue in Peanut Allergy Therapeutics Business (2018-2023)
11.6.5 GSK Recent Development
11.7 Kaleo
11.7.1 Kaleo Company Detail
11.7.2 Kaleo Business Overview
11.7.3 Kaleo Peanut Allergy Therapeutics Introduction
11.7.4 Kaleo Revenue in Peanut Allergy Therapeutics Business (2018-2023)
11.7.5 Kaleo Recent Development
11.8 Amneal Pharma
11.8.1 Amneal Pharma Company Detail
11.8.2 Amneal Pharma Business Overview
11.8.3 Amneal Pharma Peanut Allergy Therapeutics Introduction
11.8.4 Amneal Pharma Revenue in Peanut Allergy Therapeutics Business (2018-2023)
11.8.5 Amneal Pharma Recent Development
11.9 ALK Abello
11.9.1 ALK Abello Company Detail
11.9.2 ALK Abello Business Overview
11.9.3 ALK Abello Peanut Allergy Therapeutics Introduction
11.9.4 ALK Abello Revenue in Peanut Allergy Therapeutics Business (2018-2023)
11.9.5 ALK Abello Recent Development
11.10 Aimmune Therapeutics
11.10.1 Aimmune Therapeutics Company Detail
11.10.2 Aimmune Therapeutics Business Overview
11.10.3 Aimmune Therapeutics Peanut Allergy Therapeutics Introduction
11.10.4 Aimmune Therapeutics Revenue in Peanut Allergy Therapeutics Business (2018-2023)
11.10.5 Aimmune Therapeutics Recent Development
11.11 HUAPONT Pharm
11.11.1 HUAPONT Pharm Company Detail
11.11.2 HUAPONT Pharm Business Overview
11.11.3 HUAPONT Pharm Peanut Allergy Therapeutics Introduction
11.11.4 HUAPONT Pharm Revenue in Peanut Allergy Therapeutics Business (2018-2023)
11.11.5 HUAPONT Pharm Recent Development
11.12 Allergy Therapeutics
11.12.1 Allergy Therapeutics Company Detail
11.12.2 Allergy Therapeutics Business Overview
11.12.3 Allergy Therapeutics Peanut Allergy Therapeutics Introduction
11.12.4 Allergy Therapeutics Revenue in Peanut Allergy Therapeutics Business (2018-2023)
11.12.5 Allergy Therapeutics Recent Development
11.13 ASIT Biotech
11.13.1 ASIT Biotech Company Detail
11.13.2 ASIT Biotech Business Overview
11.13.3 ASIT Biotech Peanut Allergy Therapeutics Introduction
11.13.4 ASIT Biotech Revenue in Peanut Allergy Therapeutics Business (2018-2023)
11.13.5 ASIT Biotech Recent Development
11.14 Sanofi
11.14.1 Sanofi Company Detail
11.14.2 Sanofi Business Overview
11.14.3 Sanofi Peanut Allergy Therapeutics Introduction
11.14.4 Sanofi Revenue in Peanut Allergy Therapeutics Business (2018-2023)
11.14.5 Sanofi Recent Development
11.15 DBV Technologies
11.15.1 DBV Technologies Company Detail
11.15.2 DBV Technologies Business Overview
11.15.3 DBV Technologies Peanut Allergy Therapeutics Introduction
11.15.4 DBV Technologies Revenue in Peanut Allergy Therapeutics Business (2018-2023)
11.15.5 DBV Technologies Recent Development
11.16 HAL Allergy
11.16.1 HAL Allergy Company Detail
11.16.2 HAL Allergy Business Overview
11.16.3 HAL Allergy Peanut Allergy Therapeutics Introduction
11.16.4 HAL Allergy Revenue in Peanut Allergy Therapeutics Business (2018-2023)
11.16.5 HAL Allergy Recent Development
11.17 Intrommune Therapeutics
11.17.1 Intrommune Therapeutics Company Detail
11.17.2 Intrommune Therapeutics Business Overview
11.17.3 Intrommune Therapeutics Peanut Allergy Therapeutics Introduction
11.17.4 Intrommune Therapeutics Revenue in Peanut Allergy Therapeutics Business (2018-2023)
11.17.5 Intrommune Therapeutics Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Peanut Allergy Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Epinephrine Injection
Table 3. Key Players of Antihistamines
Table 4. Key Players of Oral Immunotherapy
Table 5. Key Players of Other
Table 6. Global Peanut Allergy Therapeutics Market Size Growth by Distribution Channel (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Peanut Allergy Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Peanut Allergy Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Peanut Allergy Therapeutics Market Share by Region (2018-2023)
Table 10. Global Peanut Allergy Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Peanut Allergy Therapeutics Market Share by Region (2024-2029)
Table 12. Peanut Allergy Therapeutics Market Trends
Table 13. Peanut Allergy Therapeutics Market Drivers
Table 14. Peanut Allergy Therapeutics Market Challenges
Table 15. Peanut Allergy Therapeutics Market Restraints
Table 16. Global Peanut Allergy Therapeutics Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Peanut Allergy Therapeutics Market Share by Players (2018-2023)
Table 18. Global Top Peanut Allergy Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peanut Allergy Therapeutics as of 2022)
Table 19. Ranking of Global Top Peanut Allergy Therapeutics Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Peanut Allergy Therapeutics Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Peanut Allergy Therapeutics Product Solution and Service
Table 23. Date of Enter into Peanut Allergy Therapeutics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Peanut Allergy Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Peanut Allergy Therapeutics Revenue Market Share by Type (2018-2023)
Table 27. Global Peanut Allergy Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Peanut Allergy Therapeutics Revenue Market Share by Type (2024-2029)
Table 29. Global Peanut Allergy Therapeutics Market Size by Distribution Channel (2018-2023) & (US$ Million)
Table 30. Global Peanut Allergy Therapeutics Revenue Market Share by Distribution Channel (2018-2023)
Table 31. Global Peanut Allergy Therapeutics Forecasted Market Size by Distribution Channel (2024-2029) & (US$ Million)
Table 32. Global Peanut Allergy Therapeutics Revenue Market Share by Distribution Channel (2024-2029)
Table 33. North America Peanut Allergy Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Peanut Allergy Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Peanut Allergy Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Peanut Allergy Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Peanut Allergy Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Peanut Allergy Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Peanut Allergy Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Peanut Allergy Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Peanut Allergy Therapeutics Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Peanut Allergy Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Peanut Allergy Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Peanut Allergy Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Peanut Allergy Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Peanut Allergy Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Peanut Allergy Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 48. Mylan Company Detail
Table 49. Mylan Business Overview
Table 50. Mylan Peanut Allergy Therapeutics Product
Table 51. Mylan Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million)
Table 52. Mylan Recent Development
Table 53. Bayer Company Detail
Table 54. Bayer Business Overview
Table 55. Bayer Peanut Allergy Therapeutics Product
Table 56. Bayer Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million)
Table 57. Bayer Recent Development
Table 58. UCB Pharma Company Detail
Table 59. UCB Pharma Business Overview
Table 60. UCB Pharma Peanut Allergy Therapeutics Product
Table 61. UCB Pharma Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million)
Table 62. UCB Pharma Recent Development
Table 63. J & J Company Detail
Table 64. J & J Business Overview
Table 65. J & J Peanut Allergy Therapeutics Product
Table 66. J & J Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million)
Table 67. J & J Recent Development
Table 68. Perrigo Company Detail
Table 69. Perrigo Business Overview
Table 70. Perrigo Peanut Allergy Therapeutics Product
Table 71. Perrigo Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million)
Table 72. Perrigo Recent Development
Table 73. GSK Company Detail
Table 74. GSK Business Overview
Table 75. GSK Peanut Allergy Therapeutics Product
Table 76. GSK Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million)
Table 77. GSK Recent Development
Table 78. Kaleo Company Detail
Table 79. Kaleo Business Overview
Table 80. Kaleo Peanut Allergy Therapeutics Product
Table 81. Kaleo Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million)
Table 82. Kaleo Recent Development
Table 83. Amneal Pharma Company Detail
Table 84. Amneal Pharma Business Overview
Table 85. Amneal Pharma Peanut Allergy Therapeutics Product
Table 86. Amneal Pharma Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million)
Table 87. Amneal Pharma Recent Development
Table 88. ALK Abello Company Detail
Table 89. ALK Abello Business Overview
Table 90. ALK Abello Peanut Allergy Therapeutics Product
Table 91. ALK Abello Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million)
Table 92. ALK Abello Recent Development
Table 93. Aimmune Therapeutics Company Detail
Table 94. Aimmune Therapeutics Business Overview
Table 95. Aimmune Therapeutics Peanut Allergy Therapeutics Product
Table 96. Aimmune Therapeutics Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million)
Table 97. Aimmune Therapeutics Recent Development
Table 98. HUAPONT Pharm Company Detail
Table 99. HUAPONT Pharm Business Overview
Table 100. HUAPONT Pharm Peanut Allergy Therapeutics Product
Table 101. HUAPONT Pharm Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million)
Table 102. HUAPONT Pharm Recent Development
Table 103. Allergy Therapeutics Company Detail
Table 104. Allergy Therapeutics Business Overview
Table 105. Allergy Therapeutics Peanut Allergy Therapeutics Product
Table 106. Allergy Therapeutics Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million)
Table 107. Allergy Therapeutics Recent Development
Table 108. ASIT Biotech Company Detail
Table 109. ASIT Biotech Business Overview
Table 110. ASIT Biotech Peanut Allergy Therapeutics Product
Table 111. ASIT Biotech Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million)
Table 112. ASIT Biotech Recent Development
Table 113. Sanofi Company Detail
Table 114. Sanofi Business Overview
Table 115. Sanofi Peanut Allergy Therapeutics Product
Table 116. Sanofi Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million)
Table 117. Sanofi Recent Development
Table 118. DBV Technologies Company Detail
Table 119. DBV Technologies Business Overview
Table 120. DBV Technologies Peanut Allergy Therapeutics Product
Table 121. DBV Technologies Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million)
Table 122. DBV Technologies Recent Development
Table 123. HAL Allergy Company Detail
Table 124. HAL Allergy Business Overview
Table 125. HAL Allergy Peanut Allergy Therapeutics Product
Table 126. HAL Allergy Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million)
Table 127. HAL Allergy Recent Development
Table 128. Intrommune Therapeutics Company Detail
Table 129. Intrommune Therapeutics Business Overview
Table 130. Intrommune Therapeutics Peanut Allergy Therapeutics Product
Table 131. Intrommune Therapeutics Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million)
Table 132. Intrommune Therapeutics Recent Development
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Peanut Allergy Therapeutics Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Peanut Allergy Therapeutics Market Share by Type: 2022 VS 2029
Figure 3. Epinephrine Injection Features
Figure 4. Antihistamines Features
Figure 5. Oral Immunotherapy Features
Figure 6. Other Features
Figure 7. Global Peanut Allergy Therapeutics Market Size Comparison by Distribution Channel (2023-2029) & (US$ Million)
Figure 8. Global Peanut Allergy Therapeutics Market Share by Distribution Channel: 2022 VS 2029
Figure 9. Hospital Pharmacy Case Studies
Figure 10. Retail Pharmacy Case Studies
Figure 11. Other Case Studies
Figure 12. Peanut Allergy Therapeutics Report Years Considered
Figure 13. Global Peanut Allergy Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Peanut Allergy Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Peanut Allergy Therapeutics Market Share by Region: 2022 VS 2029
Figure 16. Global Peanut Allergy Therapeutics Market Share by Players in 2022
Figure 17. Global Top Peanut Allergy Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peanut Allergy Therapeutics as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Peanut Allergy Therapeutics Revenue in 2022
Figure 19. North America Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Peanut Allergy Therapeutics Market Share by Country (2018-2029)
Figure 21. United States Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Peanut Allergy Therapeutics Market Share by Country (2018-2029)
Figure 25. Germany Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Peanut Allergy Therapeutics Market Share by Region (2018-2029)
Figure 33. China Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Peanut Allergy Therapeutics Market Share by Country (2018-2029)
Figure 41. Mexico Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Peanut Allergy Therapeutics Market Share by Country (2018-2029)
Figure 45. Turkey Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Mylan Revenue Growth Rate in Peanut Allergy Therapeutics Business (2018-2023)
Figure 48. Bayer Revenue Growth Rate in Peanut Allergy Therapeutics Business (2018-2023)
Figure 49. UCB Pharma Revenue Growth Rate in Peanut Allergy Therapeutics Business (2018-2023)
Figure 50. J & J Revenue Growth Rate in Peanut Allergy Therapeutics Business (2018-2023)
Figure 51. Perrigo Revenue Growth Rate in Peanut Allergy Therapeutics Business (2018-2023)
Figure 52. GSK Revenue Growth Rate in Peanut Allergy Therapeutics Business (2018-2023)
Figure 53. Kaleo Revenue Growth Rate in Peanut Allergy Therapeutics Business (2018-2023)
Figure 54. Amneal Pharma Revenue Growth Rate in Peanut Allergy Therapeutics Business (2018-2023)
Figure 55. ALK Abello Revenue Growth Rate in Peanut Allergy Therapeutics Business (2018-2023)
Figure 56. Aimmune Therapeutics Revenue Growth Rate in Peanut Allergy Therapeutics Business (2018-2023)
Figure 57. HUAPONT Pharm Revenue Growth Rate in Peanut Allergy Therapeutics Business (2018-2023)
Figure 58. Allergy Therapeutics Revenue Growth Rate in Peanut Allergy Therapeutics Business (2018-2023)
Figure 59. ASIT Biotech Revenue Growth Rate in Peanut Allergy Therapeutics Business (2018-2023)
Figure 60. Sanofi Revenue Growth Rate in Peanut Allergy Therapeutics Business (2018-2023)
Figure 61. DBV Technologies Revenue Growth Rate in Peanut Allergy Therapeutics Business (2018-2023)
Figure 62. HAL Allergy Revenue Growth Rate in Peanut Allergy Therapeutics Business (2018-2023)
Figure 63. Intrommune Therapeutics Revenue Growth Rate in Peanut Allergy Therapeutics Business (2018-2023)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 猫アレルギー治療薬のグローバル市場展望 2023年-2029年：抗ヒスタミン薬、副腎皮質ステロイド点鼻薬、鼻詰まり改善薬、ロイコトリエン拮抗薬、その他
  • 咳・風邪治療薬のグローバル市場展望 2023年-2029年：抗ヒスタミン薬、去痰薬、気管支拡張薬、鼻づまり改善薬、抗生物質、その他
  • 家族性カイロミクロン血症症候群治療薬の世界市場2023年：健康補助食品家族性カイロミクロン血症治療剤、遺伝子治療剤家族性カイロミクロン血症治療剤
  • セザリー症候群治療の世界市場2023年：放射線療法、化学療法、免疫療法、体外光化学療法
  • 帯状疱疹後神経痛治療の世界市場2023年：抗けいれん薬、貼付剤、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA6488 )"ピーナッツアレルギー治療薬の世界市場2023年：エピネフリン注射、抗ヒスタミン薬、経口免疫療法、その他" (英文：Global Peanut Allergy Therapeutics Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。